New On-Demand: 2024 Nuclear Pharmacy CE (12 hrs. CPE)

New On-Demand: 2024 Nuclear Pharmacy CE (12 hrs. CPE)

$275.00

ACCREDITATION

iCARE Pharmacy Services, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is an ACPE knowledge-based activity. Participants will receive 12 hours of CPE credit by attending sessions and successfully completing the CPE activity evaluation and post test with 70% or above.

 

iCARE Pharmacy Services, Inc. is approved by the Florida Board of Pharmacy as a provider of continuing pharmacy education.

DISCLOSURES

Speakers have no relevant conflict of interests nor financial relationships.  All persons in a position to control the content of this activity have declared that no conflict of interest exists for this activity.

TARGET AUDIENCE
Nuclear Pharmacists and Technicians or any pharmacist and technician interested in nuclear pharmacy education.

REGISTRATION

Purchase online at www.icarepharmacyservices.org  Pharmacist fee is $275. Technician fee is $150.

CANCELLATION POLICY
Participants must submit cancellations in writing. Participants will receive a credit for a future CPE program.

Required Computer Hardware/Software

Please ensure your computer system meets the following Zoom minimum requirements:

  • 32-bit or 64-bit processor
  • Internet Browser (MAC and/or Windows) – Internet Explorer, Google Chrome, Firefox, Safari
  • Broadband internet connection: cable, high-speed DSL and any other medium that is internet accessible. Connect to hard wired Ethernet, secondary monitor, webcam, microphone
  • Monitor Screen Resolution – HP Envy 27″ Monitoror Dual Bundle
  • Audio system – Computer speakers or headphones, laptop integrated speakers or desktop speakers
  • Media Viewing Requirements – Microsoft PowerPoint, Adobe reader
  • USB camera – Logitech Brio or C930e
Category: Tag:

Description

On-Demand: 2024 NUCLEAR PHARMACY CE

Nuclear Medicine in Pediatrics   

Elizabeth Rhoda, PharmD, RPh, Purdue University Nuclear Pharmacy Fellow

Upon completion of this activity, participants will be able to: Recognize commonly used pediatric nuclear medicine studies and protocols; Identify pearls and considerations for pediatric use of radiopharmaceuticals; Summarize key points regarding pediatric radiobiology; Evaluate different dosing methods for pediatrics and calculate correct doses for pediatrics; Explore advantages and challenges with using PET MRI vs PET CT pediatrics.

UAN: 0675-0000-24-031-H01-P/T

 

Cancer Associated Fibroblast (CAF) and Current Clinical Trial Diagnostic Agents

Garcia Simon Clark, PharmD, MS, ANP, CCP, BCNP, Kindred Healthcare, Pharmacy Supervisor

Upon completion of this activity, participants will be able to: Describe fibroblast activation protein and its role in cancer; Discuss multiple cancer type detection using fibroblast labeled with a radiotracer; Evaluate the clinical trials using fibroblast detection.

UAN: 0675-0000-24-032-H01-P/T

 

PET on the Mind: Radiopharmaceuticals for Brain Imaging

Elizabeth Rayes, PharmD, Brigham and Women’s Hospital Nuclear Pharmacy, RadioPharmacist

Upon completion of this activity, participants will be able to: Describe Beta-Amyloid and its role in Alzheimer's; Discuss the use of F18 Beta-Amyloid imaging agents; Evaluate clinical trials on the use of tau & microglial radiotracers.

UAN: 0675-0000-24-033-H01-P/T

 

Germanium 68/Gallium 68 Generator Best Practices                                      

Jay Simon, RPh, ANP, Managing Director North America, Eckert & Zeigler

Upon completion of this activity, participants will be able to: Discuss the methods for production of Gallium 68 to be incorporated into a drug product; Describe the steps of eluting a GalliPharm generator and the process of measuring the Germanium 68 breakthrough; Explain best sterile techniques when eluting the gallium generator either in an ISO 8 or ISO 5 environment.

UAN: 0675-0000-24-034-H01-P/T

 

Advancements in Pulmonary Imaging – It’s Here – Exploring Technegas

Vesper Grantham, MEd, RT(N), CNMT, Chair, Medical Imaging and Radiation Sciences, Program Director, Nuclear Medicine

Upon completion of this activity, participants will be able to: Describe the protocol features of Technegas including equipment, radiopharmaceutical administration, and imaging protocol; Discuss the advantages of Technegas over traditional ventilation imaging agents; Evaluate implementation of Technegas for nuclear medicine departments.

UAN: 0675-0000-24-035-H01-P/T

 

The U.S. Nuclear Regulatory Commission (NRC) Advisory Committee on the Medical Use of Isotopes (ACMUI)   

Richard Green, BSPharm, RPh, BCNP FAPhA,

Upon completion of this activity, participants will be able to: Discuss the ACMUI role in the NRC; Describe the current make-up of the ACMUI membership; Discuss the topics recently taken up by the ACMUI; Identify areas of future NRC action as a result of ACMUI reports.

UAN: 0675-0000-24-036-H03-P/T

 

Radiotherapeutics: Best Practice and Updates                                               

Akram Hussein, PharmD, MBA, BCNP, Director – Nuclear Medicine Radiopharmacy, MD Anderson Cancer Center

Upon completion of this activity, participants will be able to: Describe the tools and infrastructure needed for a successful radiotherapeutics program; Discuss how a commercial and hospital nuclear pharmacist can support a theranostics center; Explain medical events related to radiotherapies and how to decrease their occurrence.

UAN: 0675-0000-24-037-H01-P/T

 

Instrument Review and Best Practices for Nuclear Pharmacy                        

Wendy Galbraith, PharmD, FAPhA, BCNP, Clinical Associate Professor, University of Oklahoma, Dept. of Pharmaceutical Sciences, College of Pharmacy, Nuclear Pharmacy & Research Imaging Facility

Upon completion of this activity, participants will be able to: Describe National Institute of Standards and Technology primary and secondary sources; Explain the error rate in measuring activity from various radiopharmaceuticals; Describe how to change or add a new calibration setting on the dose calibrators.

UAN: 0675-0000-24-038-H01-P/T